Jaguar Health to Host Exclusive Virtual Educational Event “Diarrhea Dialogues: Why Bowel Control is Critical to Supportive Care in Cancer”
The MarketWatch News Department was not involved in the creation of this content.
September 24, 2020 (ACCESSWIRE via COMTEX) —
Leading Oncologists, Supportive Care Experts, and Patient Advocates Discuss Importance of Supportive Care for Cancer Patients and Address Debilitating Diarrhea Resulting from Cancer Therapy
SAN FRANCISCO, CA / ACCESSWIRE / September 24, 2020 / Jaguar Health, Inc. (NASDAQ:JAGX), a commercial stage pharmaceuticals company focused on discovering, developing, and commercializing novel, plant-based, non-opioid, and sustainably derived prescription medicines, today announced it will hold its first “Diarrhea Dialogues” virtual event on October 20 from 3:00 PM to 4:30 PM ET. The event, open to the financial and business community, will address the importance of supportive care for cancer patients as it relates to chronic lower GI tract distress, specifically with regard to debilitating diarrhea experienced as a result of cancer therapy.
Participating in the virtual event will be Jaguar leadership and distinguished